A Study of the Combination of Oxaliplatin, Capecitabine, and Herceptin (Trastuzumab) And Chemoradiotherapy in The Adjuvant Setting in Operated Patients with HER2+Gastric Or Gastro-Esophageal Junction Cancer (TOXAG Study).

dc.contributor.authorAbali, Huseyin
dc.contributor.authorYalcin, Suayib
dc.contributor.authorOnal, Huseyin Cem
dc.contributor.authorDane, Faysal
dc.contributor.authorOksuzoglu, Berna
dc.contributor.authorOzdemir, Nuriye
dc.contributor.authorMertsoylu, Huseyin
dc.contributor.authorArtac, Mehmet
dc.contributor.authorCamci, Celalettin
dc.contributor.authorKarabulut, Bulent
dc.contributor.authorBasal, Fatma Bugdayci
dc.contributor.authorBudakoglu, Burcin
dc.contributor.authorSendur, Mehmet Ali Nahit
dc.contributor.authorGoktas, Burce
dc.contributor.authorOzdener, Fatih
dc.contributor.authorCalisgan, Arzu
dc.contributor.orcIDhttps://orcid.org/0000-0002-1932-9784en_US
dc.contributor.researcherIDM-9530-2014en_US
dc.date.accessioned2023-06-16T07:59:55Z
dc.date.available2023-06-16T07:59:55Z
dc.date.issued2016
dc.identifier.issn0732-183Xen_US
dc.identifier.issue4en_US
dc.identifier.urihttp://hdl.handle.net/11727/9644
dc.identifier.volume34en_US
dc.identifier.wos000378109600176en_US
dc.language.isoengen_US
dc.relation.isversionof10.1200/jco.2016.34.4_suppl.tps182en_US
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleA Study of the Combination of Oxaliplatin, Capecitabine, and Herceptin (Trastuzumab) And Chemoradiotherapy in The Adjuvant Setting in Operated Patients with HER2+Gastric Or Gastro-Esophageal Junction Cancer (TOXAG Study).en_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: